Conference · London, United Kingdom
Strategies for Commercial Success of Biosimilars in an Increasingly Crowded Market Place
Medicine · Pharmaceuticals · Biotechnology
Key numbers
- Editions on record
- 1first in 2012
About Strategies for Commercial Success of Biosimilars in an Increasingly Crowded Market Place
Whilst biopharmaceuticals remain a major component of the global therapeutics market, the ever expanding portfolio of products losing patent protection and with increasing healthcare costs remaining a poignant issue, the opportunity for development of competing, follow on biologics remains an attractive proposition for both Biotech and Pharma companies alike. This Euroscicon biosimilars conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, biosimilar products to the market place.
This event has CPD accreditation
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2012 | 19 Apr 2012 | The Penridge Suite London, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Strategies for Commercial Success of Biosimilars in an Increasingly Crowded Market Place?
The next dates haven't been confirmed. The last edition we have on record was 19 Apr 2012.
Where is it held?
The last edition we have was at The Penridge Suite, London, United Kingdom.